Acetylcholinesterase-independent action of diisopropyl-flurophosphate in the rat aorta

European Journal of Pharmacology

Volumn 404, Issue 3, 2000, Pages 353-359

  Lim, Siew Lan ^a   Sim, Meng Kwoon ^a   Loke, Weng Keong ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

(Rat); Aorta; Diisopropyl flurophosphate; Norepinephrine; Organophosphate; Phentolami ne

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; ACETYLCHOLINESTERASE; AF DX116; ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ATROPINE; CHOLINESTERASE INHIBITOR; DYFLOS; MUSCARINIC RECEPTOR; NORADRENALIN; ORGANOPHOSPHATE; OTENZEPAD; PHENTOLAMINE; PIRENZEPINE;

ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; AORTA DISEASE; AORTA NERVE; ARTICLE; BINDING COMPETITION; CHOLINESTERASE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENDOTHELIUM INJURY; ISOLATED ARTERY; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SYMPATHETIC NERVE; TOXICITY;

ACETYLCHOLINESTERASE; ADRENERGIC ALPHA-ANTAGONISTS; ANIMAL; AORTA; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ISOFLUROPHATE; MALE; PHENTOLAMINE; RATS; RATS, SPRAGUE-DAWLEY; SUPPORT, NON-U.S. GOV'T; VASOCONSTRICTION;

EID: 0342844323     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00629-4     Document Type: Article

References (37)

1. Bakry N.M.S., El-Rashidy A.H., Eldefrawi A.T., Eldefrawi M.E. Direct actions of anticholinesterase on nicotinic and muscarinic acetylcholine receptors. J. Biochem. Toxicol. 3:1988;235-259.
2. Bataillard A., Sannajust F., Yoccox D., Blanchet G., Sentenac-Roumanou H. Cardiovascular consequences of organophosphorus poisoning and of antidotes in conscious unrestrained rats. Pharmacol. Toxicol. 67:1990;27-35.
3. Black J.W., Jenkinson D.H., Kenakin T.P. Antagonism of an indirectly acting agonist; block by propranolol and sotalol of the action of tyramines on rat heart. Eur. J. Pharmacol. 65:1980;1-10.
4. 3 muscarinic receptors of both endothelium-dependent contraction and relaxation to acetylcholine in the aorta of spontaneously hypertensive rats. Br. J. Pharmacol. 112:1994;519-524.
5. Chao Y.H., Chia Y.H., Robinson C.P. Effects of soman on vascular contractility of rabbit arteries. J. Toxicol. Environ. Health. 24:1988;201-215.
6. Dauphin F., Hamel E. Identification of multiple muscarinic binding site subtypes in cat and human cerebral vasculature. J. Pharmacol. Exp. Ther. 260:1992;660-667.
7. Day M.D. The lack of cross tachyphylaxis between tyramine and some other indirectly acting sympathomimetic amines. Br. J. Pharmacol. Chemother. 17:1967;245-260.
8. Eglen R.M., Whiting R.L. Heterogenity of vascular muscarinic receptors. J. Auton. Pharmacol. 19:1990;233-245.
9. Eglen R.M., Michel A.D., Montgomery W.W., Kunysz E.A., Machado C.A., Whiting R.L. The interaction of parafluorohexahydrosiladifenidol at muscarinic receptors in vitro. Br. J. Pharmacol. 99:1990;637-642.
10. Eglen R.M., Hegde S.S., Watson N. Muscarinic receptor subtypes and smooth muscle function. Pharmacol. Rev. 48(4):1996;531-565.
11. El-Kashef H., Catravas J.D. The nature of the muscarinic receptor subtypes mediaiting pulmonary vasoconstriction in the rabbit. Pulm. Pharmacol. 4:1991;8-19.
12. Goyal R.K. Muscarinic receptor subtypes. Physiology and clinical implications. N. Engl. J. Med. 321:1989;1022-1029.
13. Gunderso C.H., Lehman C.R., Sidell F.R., Jabbari B. Nerve agents: a review. Neurology. 42:1992;946-950.
14. Hoffman B.B., Lefkowitz R.J., Taylor P. Neurotransmission: the autonomic and somatic nervous systems. Molinoff P.B., Ruddon R.W. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 9th edn. 1996;105-139 McGraw-Hill, New York, NY.
15. Idriss M., Aguayo L.G., Rickett D.L., Albuquerque E.X. Organophosphate and carbamate compounds have pre- and post-junctional effects at the insect glutamatergic synapse. J. Pharmacol. Exp. Ther. 239:1986;279-285.
16. Kassa J., Fusek J. Effects of panpal pretreatment and antidotal treatment (HI-6 plus benactyzine) on respiratory and circulatory function in soman-poisoned rats. Hum. Exp. Toxicol. 16:1997;563-569.
17. Katz L.S., Marquis J.K. Modulation of central muscarinic receptor binding in vitro by ultralow levels of the organophosphate paraoxon. Toxicol. Appl. Pharmacol. 101:1989;114-123.
18. Kenakin T.P. Drug antagonism. Kenakin T.P. Pharmacologic Analysis of Drug-Receptor Interaction. 1987;205-244 Raven Press, New York, NY.
19. Kentera D., Susie D., Stamenkovic B. The effects of HS-3 and HS-6 on cardiovascular changes in rats by soman. Arh. Hig. Rada. Toksikol. 33:1986;143-150.
20. Langer S.Z., Hicks P.E. Alpha-adrenoceptor subtypes in blood vessels: physiology and pharmacology. J. Cardiovasc. Pharmacol. 6:1984;S547-S558.
21. Levine R.M., Birdsall N.J.M. Nomenclature for muscarinic receptor subtypes recommended by symposium. Trends Pharmacol. Sci. S10(VII):1989.
22. Maxwell L.C., Herlihy J.T., Riedel G.L. Effects of ascorbic acid and EDTA on vascular concentration-response to catecholamines. Microvasc. Res. 26:1983;81-88.
23. Maxwell D.H., Lenz D.E., Groff W.A., Kaminskis A., Froelich H.L. The effects of blood flow and detoxification on in vivo cholinesterase inhibition by soman in rats. Toxicol. Appl. Pharmacol. 88:1987;66-76.
24. 2 receptor activation. Heart Vessels. 12(4):1997;179-191.
25. Nedergaard O.A., Schrold J. Effect of atropine on vascular adrenergic neuroeffector transmission. Blood Vessels. 14:1977;325-347.
26. 3 muscarinic receptors in human pulmonary artery. Br. J. Pharmacol. 119:1996;149-157.
27. O’Rourke S.T., Vanhoutte P.M. Subtype of muscarinic receptors on adrenergic nerves and vascular smooth muscle of the canine saphenous vein. J. Pharmacol. Exp. Ther. 241:1987;64-76.
28. Obi T., Kabeyama A., Nishio A. Characterization of muscarinic receptor subtype mediating contraction and relaxation in equine coronary artery in vitro. J. Vet. Pharmacol. Ther. 17:1995;226-231.
29. Pfaffendorf M., Van Zwieten P.A. Mediation by the same muscarinic receptor subtype of phasic and tonic contractile activities in the rat isolated portal vein. Br. J. Pharmacol. 108:1993;132-138.
30. 2 receptors of rat heart have high affinity for organophosphorus anticholinesterases. Toxicol. Appl. Pharmacol. 103:1990;474-481.
31. Sim M.K., Singh M. Decreased responsivness of the aortae of hypertensive rats to acetylcholine, histamine and noradrenaline. Br. J. Pharmacol. 90:1987;147-150.
32. Solberg Y., Belking M. The role of excitotoxicity in organophosphorous nerve agents central poisoning. Trends Pharmacol. Sci. 18:1997;183-185.
33. Stewart W.C., McKay D.H. Some respiratory and cardiovascular effects of gradual sarin poisoning in the rat. Can. J. Physiol. Pharmacol. 39:1961;1001-1011.
34. Su N., Narayanan N. Age related alteration in cholinergic but not ∝-adrenergic response of rat coronary artery vasculature. Cardiovasc. Res. 27:1993;284-290.
35. Trendelenburg U. Classification of sympathomimetic amines. Blaschko H., Muscholl E. Catecholamines. Handb. Exp. Pharmacol. vol. 33:1972;336-362 Springer, Berlin.
36. Ward T.R., Ferris D.J., Tilson H.A., Mundy W.R. Correlation of the anticholinesterase activity of a series of organophosphates with their ability to compete with agonist binding to muscarinic receptors. Toxicol. Appl. Pharmacol. 122:1993;300-307.
37. 3 receptors mediate contraction in rabbit endothelium-denuded aorta in vitro. J. Auton. Pharmacol. 14:1994;283-293.